PFE price outlook: Pfizer pressing against 0.618 arc. Potential breakout toward $27.95
Pfizer, Inc. (PFE): Arc cycle analysis
Overview: Based on Arc Cycle Analysis applied to the 1D chart, Pfizer is interacting with the 0.618 Resistance Arc within the current Arc Cycle. Price is testing this Resistance Arc, suggesting the potential for a breakout toward the next Resistance Arc.
Metric | Reading |
Market bias | Bullish |
Preferred scenario | Potential Breakout / Advance Toward the Next Resistance Arc |
Primary target zone | 27.95 |
Scenario invalidation | Sustained close below $26.10 |
Current arc level | Resistance Arc (0.618) |
Cycle status | Testing Resistance Arc |
Arc integrity | Weakening |
Market outlook
Price is testing the 0.618 Resistance Arc, where continued buying pressure could result in a breakout toward the next Resistance Arc. A sustained breakout above the Resistance Arc would support continued movement toward the next Resistance Arc (0.786 Arc).
Conversely, failure to achieve a sustained 1D close above the Resistance Arc would invalidate the bullish scenario and could shift the outlook toward the next Support Arc (0.5 Arc).

Author

Mohamad Gharib
Independent Analyst
Mohamad Gharib is a Financial Markets Analyst and Quantitative Researcher with more than 18 years of experience in financial markets, including 15 years as an FX Quant Trader.


















